Authors




JB Jones, PhD, MBA

Latest:

Characterizing Obesity in a Large Health Care Delivery System.

The prevalence of obesity in the Sutter Health system between 2015 and 2020 was 35%. Differences by race/ethnicity, health insurance, smoking status, and comorbidities were examined.


Juan J. Estrada, MSc, MBA

Latest:

Patient and Clinician Experiences With Telehealth for Patient Follow-up Care

Telemedicine visits may be used with established patients for follow-up care without a loss of patient satisfaction with communication with providers and with enhanced convenience and reduced travel time; a majority may be willing to pay standard co-pays or more for this convenience. Clinicians see value in this new mode of care to enhance connections with patients.


Anne McGeary Snowden, MPH

Latest:

Patient Experience and Physician/Staff Satisfaction in Transforming Medical Homes

Becoming a medical home appears to increase physician and staff job satisfaction, but it also risks decreasing patient satisfaction with access to care.


Jerry Cade, MD

Latest:

Expert Panel: Access to Multiple Treatment Options Is Needed to Continue the Fight Against HIV

A multidisciplinary panel of HIV experts gathered in October 2016 to discuss the current state of HIV care and develop critical recommendations for Pharmacy and Therapeutics (P&T) committee members to consider when developing policies affecting their member populations who are living with HIV. This paper presents the panel’s discussion, consensus opinion, and conclusions.




David Laibson, PhD

Latest:

Testimonials Do Not Convert Patients From Brand to Generic Medication

We conducted a randomized controlled trial to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.




Eric M. Maiese, PhD

Latest:

Increasing Pharmaceutical Copayments: Impact on Asthma Medication Utilization and Outcomes

Even small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.



Shreekant Parasuraman, PhD

Latest:

Economic Implications of Weight Change in Patients With Type 2 Diabetes Mellitus

Modest weight loss (>3%) among metformin-treated patients with type 2 diabetes mellitus was associated with decreased costs, lower resource utilization, and lower rates of treatment discontinuation.


Tianna Tu, BA

Latest:

Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital Systems

Since 2015, the majority of new accountable care organizations (ACOs) have been led by physician groups rather than hospital systems. This shift requires policies that address the characteristic strengths and weaknesses of physician-led ACOs.


James B. Meigs, MD, MPH

Latest:

Food Insecurity, Healthcare Utilization, and High Cost: A Longitudinal Cohort Study

In a longitudinal study, the authors find that food insecurity is associated with greater emergency department visits, inpatient admissions, and length of stay. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.


Nicole M. Engel-Nitz, PhD

Latest:

Service Setting Impact on Costs for Bevacizumab-Treated Oncology Patients

For patients with lung or colorectal cancer, bevacizumab treatment patterns and healthcare costs varied by the setting of treatment initiation (physician office vs hospital outpatient).


Claudio Gonzalez, MD

Latest:

Cost-Effectiveness of DPP-4 Inhibitor and SGLT2 Inhibitor Combination Therapy for Type 2 Diabetes

This study evaluates the long-term cost-effectiveness of treatment involving combination therapy with dipeptidyl peptidase 4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors compared with an alternative with sulfonyureas prior to insulin initiation on a background of metformin.




Jakub P. Hlávka, PhD

Latest:

Outcome Measures for Oncology Alternative Payment Models: Practical Considerations and Recommendations

This review presents a set of evidence-based outcome measures for oncology alternative payment models, drawing on evidence from existing and proposed quality measures.



Nina R. Joyce, PhD

Latest:

Cost Sharing for Antiepileptic Drugs: Medication Utilization and Health Plan Costs

Increased out-of-pocket costs for antiepileptic drugs were associated with decreased adherence, higher healthcare utilization, and higher spending among US commercial health plan beneficiaries with epilepsy.


Hanniel D. Levenson, MS

Latest:

Cost Savings in Inpatient Oncology Through an Integrative Medicine Approach

An approach including yoga, holistic nursing, and a "healing environment" can decrease medication use, resulting in substantial cost savings in care of inpatient oncology patients.


Andrew W. Artenstein, MD

Latest:

Sharing Care in the ACO Era

The authors propose a framework considering patient complexity and certainty of diagnosis to triage encounters to the most appropriate provider in an accountable care organization.



Christopher M. Jones, PharmD

Latest:

Potential Misuse and Inappropriate Prescription Practices Involving Opioid Analgesics

A quarter of opioid recipients with commercial insurance had at least 1 indicator of potential misuse by patients or inappropriate prescription practices by providers.


Manish Mittal, PhD

Latest:

Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence

Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.


Eduardo Urdaneta, MD

Latest:

Mometasone Furoate Versus Beclomethasone Dipropionate: Effectiveness in Patients With Mild Asthma

In patients with mild asthma, mometasone furoate dry powder inhaler resulted in improved adherence and fewer exacerbations than beclomethasone dipropionate hydrofluoroalkane aerosol inhaler.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo